Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 63
Filter
1.
MMW Fortschr Med ; 164(12): 24-25, 2022 06.
Article in German | MEDLINE | ID: mdl-35731390
2.
MMW Fortschr Med ; 163(9): 26-27, 2021 05.
Article in German | MEDLINE | ID: mdl-33961245
7.
MMW Fortschr Med ; 159(15): 25, 2017 Sep.
Article in German | MEDLINE | ID: mdl-28900950
8.
MMW Fortschr Med ; 159(1): 36, 2017 Jan.
Article in German | MEDLINE | ID: mdl-28097557
10.
MMW Fortschr Med ; 158(13): 38, 2016 07.
Article in German | MEDLINE | ID: mdl-27439828
20.
Dtsch Med Wochenschr ; 140(20): 1520-3, 2015 Oct.
Article in German | MEDLINE | ID: mdl-26445256

ABSTRACT

The hepatorenal syndrome is characterized by a combination of liver cirrhosis, ascites and renal impairment. It is divided into two typs, whereby typ I is defined as acute with a doubling of creatinine within 2 weeks and type II as a more modest decline of kidney function. The only definite therapy so far is transplantation. However, based on pathophysiological considerations a number of strategies have been applied. Aldosteronantagonists are the backbone of therapy even in cases of poor diuresis. Additional benefit is derived from a combination of vasopressors and albumine.


Subject(s)
Hepatorenal Syndrome/therapy , Liver Failure/therapy , Liver Transplantation , Mineralocorticoid Receptor Antagonists/therapeutic use , Vasoconstrictor Agents/therapeutic use , Hepatorenal Syndrome/blood , Hepatorenal Syndrome/diagnosis , Humans , Liver Failure/blood , Liver Failure/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...